Andrew Yule & Company Intrinsic Value
Andrew Yule & Company intrinsic value. Andrew Yule & Company (ANDREWYU) median intrinsic value is ₹50.68 from 3 valuation models (range ₹22–₹63), vs current price ₹25.34 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Compare with ANDREWYU fair value estimate to assess whether the stock is under or overvalued.
ANDREWYU Valuation Methods Summary — DCF, Graham Number & P/E
Andrew Yule & Company intrinsic value across 3 models vs current price ₹25.34 — upside/downside and value range per method. For current market price and key ratios, visit ANDREWYU share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹63.35 | ₹57.02 - ₹69.69 | +150.0% | Book Value/Share: ₹33.16, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹50.68 | ₹45.61 - ₹55.75 | +100.0% | Revenue/Share: ₹40.41, P/S: 1.5x |
| Simple DCF (5Y) | dcf | ₹21.79 | ₹17.43 - ₹26.15 | -14.0% | CF Growth: 5.0%, Discount: 15% |
ANDREWYU Intrinsic Value vs Market Price — All Valuation Models
Andrew Yule & Company fair value range ₹22–₹63 vs current market price ₹25.34 across 3 valuation models. Read ANDREWYU dividend growth for the complete payout history and dividend yield track record.
ANDREWYU Intrinsic Value Analysis — Undervalued or Overvalued?
Andrew Yule & Company median intrinsic value ₹50.68, current price ₹25.34 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of ANDREWYU?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Andrew Yule & Company (ANDREWYU) is ₹50.68 (median value). With the current market price of ₹25.34, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹21.79 to ₹63.35, indicating ₹21.79 - ₹63.35.
Is ANDREWYU undervalued or overvalued?
Based on our multi-method analysis, Andrew Yule & Company (ANDREWYU) appears to be trading below calculated value by approximately 100.0%.
ANDREWYU Financial Health — Key Ratios vs Industry Benchmarks
Andrew Yule & Company financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.49 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -38.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -54.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.53x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ANDREWYU Cash Flow Quality — Operating & Free Cash Flow
Andrew Yule & Company operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-38 Cr | ₹-38 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-11 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹23 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹54 Cr | ₹40 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-63 Cr | ₹-63 Cr | Negative Cash Flow | 3/10 |